Analyst Juan C. Sanabria from BMO Capital maintained a Buy rating on Healthpeak Properties (DOC – Research Report) and keeping the price target at $24.00.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Juan C. Sanabria’s rating is based on a combination of factors that highlight the strong performance and strategic actions of Healthpeak Properties. The company reported a robust first quarter in 2025, with a solid same-store net operating income growth of 7.0%, driven by increases in both medical office buildings and lab spaces. This performance indicates a stable and growing portfolio, which is a positive sign for investors.
Additionally, Healthpeak Properties has been proactive in capitalizing on market conditions by repurchasing $94 million worth of shares at a significant discount, which reflects a strategic approach to enhance shareholder value. Despite the political uncertainties, the company’s lab leasing activities remain strong, with a healthy tenant retention rate and positive leasing spreads. These factors, coupled with the maintained guidance for adjusted funds from operations, support Sanabria’s confidence in the company’s future performance, justifying the Buy rating.
C. Sanabria covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, CareTrust REIT, and Public Storage. According to TipRanks, C. Sanabria has an average return of 0.0% and a 45.08% success rate on recommended stocks.